Tuberculosis and its control: lessons to be learned from past experience, and implications for leprosy control programmes.
D000293:Adolescent; D000328:Adult; D001500:BCG Vaccine; D002648:Child; D002675:Child, Preschool; D003906:Developing Countries; D004352:Drug Resistance, Microbial; D006801:Humans; D007223:Infant; D007538:Isoniazid / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy / Q000517:prevention & control*; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*
D001500:BCG Vaccine; D007538:Isoniazid; D012293:Rifampin